Review
Published on 26 Nov 2024
Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1501613
- 251 views
Type at least 3 characters
6,716 articles
Articles
Original Research
Accepted on 25 Nov 2024
Prognostic Significance of Combined PD-L1 Expression in Malignant and Infiltrating Cells in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1506355
Original Research
Accepted on 25 Nov 2024
Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1486652
Opinion
Accepted on 25 Nov 2024
Revisiting Immune Checkpoint Inhibitors: New Strategies to Enhance Efficacy and Reduce Toxicity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1490129
Original Research
Accepted on 25 Nov 2024
Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma cell
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1501486
Original Research
Accepted on 25 Nov 2024
Assessing Immunotherapy Response: Going Beyond RECIST by Integrating Early Tumor Growth Kinetics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1470555
Original Research
Accepted on 25 Nov 2024
Mitochondria-Associated Programmed Cell Death: Elucidating Prognostic Biomarkers, Immune Checkpoints, and Therapeutic Avenues in Multiple Myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1448764
Review
Accepted on 25 Nov 2024
Alternative Splicing of Modulatory Immune Receptors in T Lymphocytes: A Newly Identified and Targetable Mechanism for Anticancer Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1490035
Original Research
Accepted on 25 Nov 2024
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: A systematic literature review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1499478
Review
Accepted on 25 Nov 2024
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1513421
Original Research
Accepted on 25 Nov 2024
Diagnostic value of multi-tumor-associated autoantibody expression in esophageal squamous cell carcinoma and correlation of clinical features
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1518431
Brief Research Report
Accepted on 25 Nov 2024
Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1456193
Case Report
Accepted on 25 Nov 2024
Case Report: Systemic Sclerosis During Neoadjuvant Therapy for Breast Cancer in a 59-Year-Old Woman
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1487508
Original Research
Accepted on 25 Nov 2024
SOX13 as a Potential Prognostic Biomarker Linked to Immune Infiltration and Ferroptosis Inhibits the Proliferation, Migration, and Metastasis of Thyroid Cancer Cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1478395
Original Research
Published on 25 Nov 2024
Cost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1477146
- 397 views
Brief Research Report
Published on 25 Nov 2024
Associations between glycan signature alterations and the cellular antigenic properties of passaged chondrocytes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1475473
- 196 views